MedTrace Logo

Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)

NCT00001206 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 347

Last updated 2019-12-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate individuals with Attention Deficit/Hyperactivity Disorder (ADHD) to learn more about the genetics of the disease.

This study is part of other ongoing studies of individuals with ADHD. The study participants have already undergone neurobiological measurements, particularly magnetic resonance imaging (MRI) of the brain, through other research studies. As a follow-up to these studies, participants will next undergo psychiatric interviews, neuropsychological tests, and another MRI. In addition to the clinical evaluation of the participants, further research will be conducted on the genetics of ADHD. These genetic studies will evaluate people with ADHD as well as their family members and a control group of healthy people.

Conditions

  • Attention Deficit and Disruptive Behavior Disorder
  • Attention Deficit Disorder With Hyperactivity

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    lead NIH

Principal Investigators

  • Judith L Rapoport, M.D. · National Institute of Mental Health (NIMH)

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1985-06-05
Completion
2017-05-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00001206 on ClinicalTrials.gov